Operating
Net income from discontinued operations
Over 4 years (FY 2021 to FY 2025), Net income from discontinued operations shows an upward trend with a -51.0% CAGR.
Analysis
StatementCash Flow Statement
SectionOperating
CategoryProfitability
SignalContext dependent
VolatilityVolatile
First reportedQ1 2013
Last reportedQ1 2026May 5, 2026
How to read this metric
A loss may indicate costs associated with exiting a business, while a gain reflects successful divestiture or final earnings from a legacy unit.
Detailed definition
This metric reflects the net earnings or losses generated by business segments that the company has disposed of or class...
Peer comparison
Common in large conglomerates undergoing restructuring; peers often report this to clarify core operational performance.
Metric ID:
operating_income_loss_from_discontinued_operations_net_of_taxHistorical Data
20 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | -$236.00M | -$13.00M | -$186.00M | -$9.00M | $34.00M | -$21.00M | $2.00M | $1.00M | -$2.00M | $12.00M | -$26.00M | -$5.00M | $17.00M | -$8.00M | $7.00M | $0.00 | $25.00M | $0.00 | $0.00 | -$13.00M |
| QoQ Change | — | +94.5% | <-999% | +95.2% | +477.8% | -161.8% | +109.5% | -50.0% | -300.0% | +700.0% | -316.7% | +80.8% | +440.0% | -147.1% | +187.5% | -100.0% | — | -100.0% | — | — |
| YoY Change | — | — | — | — | +114.4% | -61.5% | +101.1% | +111.1% | -105.9% | +157.1% | <-999% | -600.0% | +950.0% | -166.7% | +126.9% | +100.0% | +47.1% | +100.0% | -100.0% | — |
Range-$236.00M – $34.00M
CAGR-45.7%
Avg YoY Growth-41.8%
Median YoY Growth+100.0%
Net income from discontinued operations at Other Companies
Frequently Asked Questions
- What is Pfizer's net income from discontinued operations?
- Pfizer (PFE) reported net income from discontinued operations of -$13.00M in Q1 2026.
- What is the long-term trend for Pfizer's net income from discontinued operations?
- Over 4 years (2021 to 2025), Pfizer's net income from discontinued operations has grown at a -51.0% compound annual growth rate (CAGR), from -$434.00M to $25.00M.
- What does net income from discontinued operations mean?
- Profit or loss from business units the company has sold or shut down.